Cargando…

‘Biomarking’ infection during continuous renal replacement therapy: still relevant?

Detalles Bibliográficos
Autores principales:	Honore, Patrick M, Jacobs, Rita, Hendrickx, Inne, De Waele, Elisabeth, Van Gorp, Viola, Spapen, Herbert D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488982/ https://www.ncbi.nlm.nih.gov/pubmed/26002320 http://dx.doi.org/10.1186/s13054-015-0948-z

Ejemplares similares

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?
por: Honore, Patrick M., et al.
Publicado: (2015)

Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015)

Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
por: Honore, Patrick M, et al.
Publicado: (2015)

Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
por: Honore, Patrick M., et al.
Publicado: (2015)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Renal tubular acidosis with hyperchloremic acidosis: harmless with a sting?
por: Honore, Patrick M., et al.
Publicado: (2015)

Predicting acute kidney injury in severe trauma. A biomarker breakthrough?
por: Honore, Patrick M., et al.
Publicado: (2015)

Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016)

To counteract or to clear high-mobility group box-1 protein in influenza A (H1N1) infection? That may become the question
por: Honore, Patrick M., et al.
Publicado: (2015)

Peri-operative fluid strategy and post-operative acute kidney injury in cardiac surgery patients: any role for pre-operative statin therapy?
por: Honore, Patrick M., et al.
Publicado: (2015)

Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge
por: Honore, Patrick M., et al.
Publicado: (2015)

Metabolic and coagulation effects of citrate: down to the last detail!
por: Honore, Patrick M., et al.
Publicado: (2015)

Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015)

The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
por: Honore, Patrick M, et al.
Publicado: (2015)

Alleviating central venous oxygen saturation (S(cv)O(2)): a new approach of kidney protection after cardiac surgery?
por: Honore, Patrick M., et al.
Publicado: (2015)

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
por: Jacobs, Rita, et al.
Publicado: (2015)

Biomarkers in critical illness: have we made progress?
por: Honore, Patrick M, et al.
Publicado: (2016)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014)

What's new in emergencies, trauma, and shock: Intentional or accidental hypothermia in Intensive Care Unit patients: Time to strike the colors?
por: Honore, Patrick M., et al.
Publicado: (2016)

Prevention and treatment of sepsis-induced acute kidney injury: an update
por: Honore, Patrick M., et al.
Publicado: (2015)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Colistin pharmacokinetics/pharmacodynamics and acute kidney injury: A difficult but reasonable marriage
por: Honore, Patrick M., et al.
Publicado: (2014)

Prognosis of extremely severe lactic acidosis in metformin-treated patients with septic shock: continuous (?) renal replacement therapy in the spotlight!
por: Honore, Patrick M., et al.
Publicado: (2016)

Anidulafungin dosing during CRRT: do not underestimate adsorption!
por: Honore, Patrick M, et al.
Publicado: (2014)

Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011)

Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!
por: Honore, Patrick M., et al.
Publicado: (2016)

VCO(2) calorimetry: stop tossing stones, it’s time for building!
por: De Waele, Elisabeth, et al.
Publicado: (2016)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

High-frequency percussive ventilation in acute respiratory distress syndrome: knocking at the door but can it be let in?
por: Spapen, Herbert, et al.
Publicado: (2018)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

Critical care nephrology: could it be a model of multidisciplinarity in ICU nowadays for other sub-specialities – the jury is out
por: Honoré, Patrick M, et al.
Publicado: (2014)

Biomarkers for early diagnosis of AKI in the ICU: ready for prime time use at the bedside?
por: Honore, Patrick M, et al.
Publicado: (2012)

Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration
por: Honore, Patrick M, et al.
Publicado: (2013)

A fresh look into the pathophysiology of ischemia-induced complications in patients with chronic kidney disease undergoing hemodialysis
por: Honore, Patrick M, et al.
Publicado: (2015)

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
por: Honore, Patrick M., et al.
Publicado: (2019)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019)

What a Clinician Should Know About a Renal Replacement Membrane?
por: Honore, Patrick M., et al.
Publicado: (2018)

Modification of Nutrition Therapy During Continuous Renal Replacement Therapy in Critically Ill Pediatric Patients: A Narrative Review and Recommendations
por: Jonckheer, Joop, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vb1mps85m6ornch9f956ib14sc